NumFin

Abiomed, Inc.

Symbol: ABMD

NASDAQ

381.02

USD

Market price today

  • 126.8485

    P/E Ratio

  • -5.7181

    PEG Ratio

  • 17.18B

    MRK Cap

  • 0.00%

    DIV Yield

Abiomed, Inc. (ABMD) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Abiomed, Inc. (ABMD). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Abiomed, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

balance-sheet.row.cash-and-short-term-investments

3092.52758.6583.7443.1
491.7
362.2
229.9
212.1
132
76.6
76.7
77.2
60.3
58.3
57.2
38.3
75.1
30.8
41.5
27.3
54.4
71.3
92.5
106.4
18.2
26.4
9.4
10.6
0.6
0.5
0.7
4.7
8.1
24.6
10.4
13.3
2.4

balance-sheet.row.short-term-investments

2452.62625.8351250.8
370.7
319.3
190.9
163.8
109.6
55.7
67.3
71.2
54.5
53.5
55.4
36.3
5.5
23
33.9
20.4
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

365.1490.697.284.7
90.8
70
54.1
42.8
31.8
24.4
22.9
20.5
15.4
13.5
15.7
14.1
10.9
8.9
8.6
6
5.4
7.3
10
6.7
6.4
5.4
4.8
2.6
1.8
1.7
0.8
0.6
0.7
0.7
0.8
0.5
0.2

balance-sheet.row.inventory

381.799481.190.1
80.9
50.2
34.9
26.7
16.8
13.9
14.9
11.1
7.5
9.2
14.8
17.4
8.6
4.9
3.9
2.7
2.9
4.2
3.7
3.5
2.9
2.3
1.8
1.7
1.4
2.2
1.5
0.9
1.2
1.1
0.9
0.6
0.4

balance-sheet.row.other-current-assets

145.1933.32618
13.7
11.8
8
6.8
39.6
3.1
2
1.7
1.5
1.7
0.8
1.7
1.8
1.9
1.2
1
0.9
0.8
0.8
0.5
0.3
0.2
0.2
0.1
3.9
2.7
9
13.8
14
0.2
0.1
0
0.4

balance-sheet.row.total-current-assets

3984.64976.5788635.9
677.2
494.3
327
288.4
220.1
118
116.6
110.5
84.7
82.7
88.5
71.5
96.4
46.4
55.2
37
63.6
83.7
107
117.1
27.8
34.3
16.2
15
7.7
7.1
12
20
24
26.6
12.2
14.4
3.4

balance-sheet.row.property-plant-equipment-net

827.51212203.2176.7
145
117.2
87.8
23.2
9.1
6.9
6.5
6.4
6.3
6.8
7.8
7.6
5.8
4.8
2.8
3.2
4
4.7
4.8
4
3.9
3.7
1.9
0.6
0.5
0.6
0.7
0.6
1.1
1.1
0.3
0.3
0.3

balance-sheet.row.goodwill

302.0576.878.632
32.6
35.8
31
33
31.5
38
35.4
36.8
38.9
37.2
31.3
31.6
26.7
19.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

190.6345.647.522.6
15.2
16.7
14.5
15.4
14.7
0
0
0.1
1.6
3
4.4
6.9
7.3
8.2
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

492.68122.412654.5
47.8
52.5
45.5
48.4
46.2
38
35.4
37
40.6
40.1
35.7
38.5
34
27.3
0.9
0.8
0.7
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0.3
0
0
0
0

balance-sheet.row.long-term-investments

1311.42351.9365.7302.2
21.7
37.5
47.1
1
14
41.8
11.4
0
0
0
3.7
0
0
0
2.1
18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

50.2110.611.443.3
77.5
70.7
34.7
58.5
45.2
0
0
0
0
0
0
0
0
0.3
-2.1
-18.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0003.8
85.1
14.2
8.3
4.4
3.7
0.8
0
0
0
0
0.3
0.5
0
-0.3
2.1
18.2
0
1.1
6.3
0.7
1.3
0.6
0.5
0.6
6.5
7.6
9.5
5
4.5
0
0
0
0

balance-sheet.row.total-non-current-assets

2681.81696.9706.4580.6
377.1
292.1
223.5
135.5
118.2
87.4
53.4
43.4
46.9
46.9
47.5
46.5
39.8
32.1
5.8
22.2
4.8
5.8
11
4.6
5.1
4.3
2.4
1.2
7
8.3
10.4
5.8
5.9
1.1
0.3
0.3
0.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.account-payables

137.2835.334.832.8
32.2
23.6
20.6
9.4
10.4
7.7
7.7
6.9
6.3
3.8
5.5
9
5.2
3.1
1.1
1.4
1.1
2
2.1
1.6
0.9
2.1
1.3
0.8
0.2
0.4
0.5
0.4
0.3
0
0
0
0

balance-sheet.row.short-term-debt

66.6706675.1
12.3
4.6
0.8
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

20.021.95.921.6
12.3
4.6
3.2
2.5
1.5
1.4
2.1
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
0
15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
-15.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

235.3176.73.84.9
45.2
41.6
37.7
25.9
20.4
16.5
13.1
11.5
14.1
13
10.8
9.3
7
5.2
3.6
3.3
4.2
5.6
5.6
6.4
4.8
2.9
2
1.5
1.2
0.7
0.7
0.8
0.6
1.3
1.2
1.2
1.4

balance-sheet.row.total-non-current-liabilities

114.1331.635.719.1
11.5
12.2
28.7
8.6
7.5
6.6
5.9
5.2
4.5
3.5
2.4
5
1.2
0.3
0
0
0
0
0.4
0.7
0.2
0.7
0
0
0
3.7
8.7
8.3
7.8
0
0
0
-0.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

654.2170.1164.7151
117.5
96.9
98.3
55.2
46.8
37.1
32.9
27.6
26.8
21.6
20
24.4
14.1
9
4.9
4.8
6.2
10.2
9.3
8.9
5.9
5.6
3.3
2.3
1.4
4.8
9.9
9.5
8.7
1.3
1.2
1.2
1.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1.820.50.50.5
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

4012.96964.5828602.5
399.5
140.5
-47
-99.1
-137.2
-250.9
-258.3
-273.3
-274.8
-263
-244
-212.4
-171.2
-143.3
-113.9
-111.5
-102.1
-84.4
-53.1
-41.7
-31.2
-24.5
-22
-22.8
-23.2
-22.9
-20.9
-17
-11.9
-5.3
-3.4
-1.1
-0.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-132.56-27.2-11.4-11.2
-14.7
-4.2
-20.6
-14.5
-17.3
-0.7
-3.7
-1.8
0.7
-1
-1.7
5
0.6
-2.1
-0.3
-0.1
-8.6
3.1
3.1
-5.4
-3.9
-2.7
-2.6
-2.3
-2.1
-1.9
-1.6
-1.4
-1.1
-0.8
-0.7
-0.5
-0.3

balance-sheet.row.other-total-stockholders-equity

2130.03565.5512.7473.7
551.7
552.8
519.2
482
445.7
419.6
398.7
400.9
378.4
371.6
361.3
300.7
292.4
214.6
170.1
165.7
172.5
160.4
158.4
159.9
62.1
60.2
39.8
39
38.6
35.4
35
34.7
34.2
32.5
15.4
15.1
3.3

balance-sheet.row.total-stockholders-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-stockholders-equity

6666.451673.41494.41216.5
1054.3
786.4
550.4
423.9
338.4
205.4
170
153.9
131.6
129.6
136
118
136.2
78.5
61.1
59.2
68.3
89.5
118
121.8
33
38.6
18.5
16.2
14.7
15.4
22.4
25.8
29.9
27.7
12.5
14.7
3.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

6012.251503.31329.71065.5
936.9
689.5
452.1
368.8
291.6
168.4
137.1
126.3
104.7
108
116
93.6
122.1
69.5
56.2
54.3
62.1
79.3
108.7
112.9
27.1
33
15.2
13.9
13.3
10.6
12.5
16.3
21.2
26.4
11.3
13.5
2.4

balance-sheet.row.total-liabilities-and-total-equity

6666.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

3764.04977.7716.7553
392.4
356.8
238.1
164.8
123.6
97.4
78.7
71.2
54.5
53.5
59.1
36.3
5.5
23
36
38.6
9.9
25.7
2
4.5
8.9
23.7
7.7
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0000
0
0
16.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-639.9-132.8-232.7-192.3
-121
-43
-22.7
-48.2
-22.4
-20.9
-9.5
-6
-5.8
-4.8
-1.8
-2
-69.6
-7.8
-7.6
-6.9
-44.6
-45.6
-90.2
-101.7
-9.3
-2.7
-1.6
-2.9
-0.6
-0.5
-0.7
-4.7
-8.1
-24.6
-10.4
-13.3
-2.4

Cash Flow Statement

The financial landscape of Abiomed, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991

cash-flows.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6

cash-flows.row.depreciation-and-amortization

27.5628.124.120.4
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3

cash-flows.row.deferred-income-tax

-13.22.429.433
-7.7
42.6
25.8
22.3
-87.1
0.9
0.8
0.8
1
1
0.7
0.5
0.5
0.3
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

53.7552.74739.8
54.5
40.4
32.9
29.1
16.5
11.2
9.5
7.8
5.4
5.4
8.8
5.4
5.8
0.4
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-23.26-30.2-17.48
-38.8
-18.9
5.3
-15.6
-4.7
-0.5
-2.8
-11.7
0.5
3.6
-3.5
-8
-2.5
2.8
-4.1
-2.1
-0.2
-0.4
-3.5
1.5
-2.1
0.9
-1.4
-0.3
1.1
-1.8
-0.8
0.9
-0.7

cash-flows.row.account-receivables

-8.515.3-12.15.6
-22
-15.3
-11.6
-10.9
-8
-1.3
-2.6
-5.3
-1.9
2.2
-2.5
-2.8
-1.9
0.3
-2.6
-0.6
1.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-36-29.32.5-13.2
-37.2
-15.7
-12.3
-11.5
-7
-0.6
-5.3
-6.2
-1.5
0.9
-1.6
-11.1
-4.1
-0.2
-1.2
0.2
1.4
-0.7
-0.1
-0.7
-0.6
-0.9
-0.2
-0.2
0.8
-0.7
-0.7
0.3
-0.1

cash-flows.row.account-payables

8.480.62.62.6
8
4.4
7.6
-2.6
3.4
-0.1
1.2
0.3
2.5
-1.4
-2.4
3.2
1.6
1.3
-0.2
0.3
-0.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

12.77-6.8-10.513.1
12.4
7.6
21.6
9.4
6.8
1.5
3.9
-0.5
1.4
1.8
3
2.6
2
1.4
-0.2
-2
-2.1
0.3
-3.4
2.1
-1.5
1.8
-1.2
0
0.3
-1.1
-0.1
0.6
-0.6

cash-flows.row.other-non-cash-items

-60.6395.8-3410.7
-28.8
5.3
-7.2
-0.4
2.1
2.1
1.2
1
2.5
-3.1
2.2
8.1
0.3
13.9
0.1
0
0.5
0.3
0
0
0
0
0
0
-0.2
0.1
0.1
0.2
3

cash-flows.row.net-cash-provided-by-operating-activities

250.98000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.acquisitions-net

0-82.8-52.20
0
0
0
0
-15.7
0
0
1.7
3.8
4.6
5.6
0
0
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-745.81-805.9-582.3-632.2
-404.3
-331.8
-281.4
-261.7
-100.5
-87.8
-49.4
-24.5
-8
-11.9
-60.2
-66.4
-17.7
-29
-39.5
-39
-14.6
-38
-27
-8.3
-25.5
0
0
0
-1.3
-2.9
-4.3
0
0

cash-flows.row.sales-maturities-of-investments

616.66543.5464.5550.8
331.9
206.9
205.5
219.6
71.5
68.3
42
8.8
7
17.8
37.1
34.5
35.2
42
42.2
10.2
30.4
14.4
29.4
12.7
40.4
0
0
2.7
0
6.2
4.9
0
5.5

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
-1.7
-3.4
0
-5.6
-5.1
0
0
0
0
-0.1
0
0
0
0
-2.5
0
-0.8
0.7
0
0.1
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

-162.91-381-223.3-125.5
-116.5
-180.8
-126.3
-57.7
-49.9
-22.3
-10.3
-17.5
-2.4
8.8
-26.8
-40.9
15.1
7.4
1.9
-29.2
14.8
-25.2
-0.1
3.1
13.3
-18.5
-1.6
1.6
-0.7
3.1
0.4
-0.1
5.2

cash-flows.row.debt-repayment

0000
0
-0.5
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

10.357.25.55.1
3.1
2.4
1.7
1.1
0.8
-0.3
-0.3
0.4
0.3
0.3
42.2
3.9
66.6
2.2
4.1
1.6
0.3
1
0.9
96.3
0.8
20.3
0.5
0.1
0
0.1
0.1
0.1
1.4

cash-flows.row.common-stock-repurchased

-126.620-11.3-84.9
0
0
0
0
0
-0.4
-15.3
0
0
0
0
-1.9
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-19.26-9.4-2.2-37.9
-58.8
-11
2.6
6
8.7
10.3
3.7
14.3
1.1
0.6
4
0
0
0
0
0
-0.1
-0.5
-0.2
0.6
0
0
0
0
0
0
-0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-135.53-2.2-8.1-117.7
-55.8
-9.1
3.9
7.2
9.5
9.6
-11.8
14.7
1.4
1
46.2
2.1
66.6
2.1
4.1
1.6
0.3
0.5
0.6
96.9
0.8
20.3
0.5
0.1
0
0.1
0
0.1
1.4

cash-flows.row.effect-of-forex-changes-on-cash

-12.08-2.1-2.8-0.4
-1.9
1.3
-1.8
-0.4
-1.5
0.6
-0.9
-0.7
0.4
0.6
-1.4
0.1
0
0.1
-0.1
0.1
0
0
0
0
0
0
0
0
0
0.3
0
3.5
-1.2

cash-flows.row.net-change-in-cash

-59.55-99.940.471.3
78
3.9
-9.2
25.8
1.5
11.5
3.5
0.2
1
3
-0.3
-67.6
61.8
0.2
0.8
-37.7
-1.1
-44.8
-11.5
92.6
6.6
1.1
-1.3
2.3
0.2
0.1
-3.9
0.1
1.4

cash-flows.row.cash-at-end-of-period

639.9132.8232.7192.3
121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.9
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.7
0.8
0.8
8.1
6.8

cash-flows.row.cash-at-beginning-of-period

699.45232.7192.3121
43
39
48.2
22.4
20.9
9.5
6
5.8
4.8
1.8
2
69.6
7.8
7.6
6.8
44.6
45.7
90.5
101.9
9.3
2.7
1.6
2.9
0.6
0.5
0.7
4.7
8
5.4

cash-flows.row.operating-cash-flow

250.98285.4274.6314.9
252.2
192.5
115.1
76.8
43.3
23.5
26.4
3.6
1.6
-7.4
-18.3
-28.9
-19.8
-9.3
-5.2
-10.1
-16.2
-20.1
-12
-7.3
-7.4
-0.7
-0.2
0.6
0.9
-3.4
-4.3
-3.4
-4

cash-flows.row.capital-expenditure

-33.76-35.8-53.4-44
-44
-55.9
-50.4
-15.6
-5.2
-2.8
-2.8
-1.7
-1.8
-1.8
-3.8
-3.8
-2.4
-3.1
-0.7
-0.4
-0.8
-1.6
-2.6
-1.4
-1.6
-16
-1.6
-0.3
-0.1
-0.2
-0.3
-0.1
-0.2

cash-flows.row.free-cash-flow

217.22249.6221.2270.9
208.2
136.7
64.7
61.2
38.1
20.7
23.6
1.9
-0.2
-9.2
-22.1
-32.7
-22.2
-12.4
-5.9
-10.6
-17
-21.7
-14.5
-8.7
-9
-16.7
-1.8
0.2
0.8
-3.6
-4.6
-3.5
-4.2

Income Statement Row

Abiomed, Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of ABMD is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987

income-statement-row.row.total-revenue

1074.11031.8847.5840.9
769.4
593.7
445.3
329.5
230.3
183.6
158.1
126.4
101.2
85.7
73.2
58.9
50.6
43.7
38.2
25.7
23.3
26.9
24.9
22.5
22.1
22.4
16.5
12.8
9.2
6.7
3.4
2.7
2
3
2.9
4.2
4.7

income-statement-row.row.cost-of-revenue

200.59188.2161.9151.3
129.6
98.6
70.6
50.4
39.9
37.3
31.6
24.5
22
22.5
20.4
15.1
12
11.7
9.4
7.6
7.5
7.9
7.4
5.9
6.8
6.5
5.4
3.9
2.9
1.9
3
2
1.3
1
1.1
0.2
3.7

income-statement-row.row.gross-profit

873.51843.6685.6689.6
639.9
495.2
374.7
279.1
190.4
146.3
126.5
101.9
79.2
63.2
52.8
43.9
38.6
32
28.9
18.1
15.8
18.9
17.5
16.6
15.3
15.9
11.1
8.9
6.3
4.8
0.4
0.7
0.7
2
1.8
4
1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

167.22---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.operating-expenses

619.4586.9456.1440.4
415.1
338
284.5
214
161.7
138
110
100.3
90.4
88.3
82.3
80.4
66.3
62.3
32.1
28.4
35.3
43.6
35.1
28.2
23.2
16.9
10.9
9
7.2
7.1
4.9
7
9.1
5.4
5
5.3
1.1

income-statement-row.row.cost-and-expenses

819.99775618591.7
544.6
436.6
355.2
264.4
201.6
175.3
141.6
124.9
112.3
110.8
102.7
95.4
78.4
74
41.5
36
42.8
51.5
42.5
34.1
30
23.4
16.3
12.9
10.1
9
7.9
9
10.4
6.4
6.1
5.5
4.8

income-statement-row.row.interest-income

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.58051.9-4.6
30.4
-0.4
-0.3
0.3
-0.1
0
0.3
1.5
1.4
1.5
1.6
2.8
1.6
1.3
13.2
13.6
20.4
0
0
0
0
-1.2
0
0
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.total-operating-expenses

87.06-182.158.77.6
38.5
3.3
1.2
0.7
0.1
0.2
0.3
1
0.3
6.7
-1.3
-5.1
0.3
0
0.1
0.2
0.2
0
0
0
0
0
0
0
0.4
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.interest-expense

94.2449.800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

30.4828.117.48.3
14.1
11
6.2
3.3
2.8
2.5
2.7
4.3
3.9
4.9
5
6.1
3.9
2.7
1.2
1.4
1.7
1.8
3
1.7
1.4
0.9
0.4
0.3
0.4
0.3
0.3
0.6
0.3
0.2
0.2
0.2
0.2

income-statement-row.row.ebitda-caps

284.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

253.61372.7229.6249.2
224.8
157.1
90.1
65.1
28.7
8.4
16.5
1.5
-11.2
-25.1
-29.5
-36.5
-28.5
-30.3
-3.3
-10.3
-19.5
-24.6
-17.6
-11.6
-7.9
-1
0.2
0
-0.9
-2.3
-4.5
-6.3
-8.4
-3.4
-3.2
-1.3
-0.1

income-statement-row.row.income-before-tax

341.16190.6288.2256.8
263.4
160.4
91.3
65.8
28.8
8.5
16.9
2.5
-10.9
-18.4
-30.8
-40.4
-27.4
-29.1
-2.3
-9.4
-18.2
0
0
0
0
0
0
0
-0.5
-1.9
-3.9
-5.1
-6.7
-1.9
-2.3
-0.6
0.1

income-statement-row.row.income-tax-expense

74.454.162.753.8
4.3
48.3
39.2
27.7
-84.9
1.2
1.8
1
0.9
0.7
0.8
0.5
0.5
0.4
0.1
0.2
0.2
-2.9
-6.2
-1.1
-1.2
1.5
-0.5
-0.5
-0.5
0.4
0.6
1.2
1.7
1.5
0.9
0.7
0.2

income-statement-row.row.net-income

266.76136.5225.5203
259
112.2
52.1
38.1
113.7
7.4
15
1.5
-11.8
-19
-31.6
-40.9
-27.9
-29.4
-2.3
-9.4
-18.2
-21.7
-11.4
-10.5
-6.7
-2.5
0.7
0.5
-0.4
-2
-3.9
-5.1
-6.6
-1.9
-2.2
-0.6
0.1
Similar Stocks
You may also be interested in:
EAR
Eargo, Inc..
2.58 USD
NASDAQ
ELEAF
EL.En. S.p.A..
9.8 USD
PNK
FORZ
Forza Innovations Inc..
0.0001 USD
PNK
SILK
Silk Road Medical, Inc.
18.97 USD
NASDAQ
UNIVPHOTO.NS
Universus Photo Imagings Limited.
391 INR
NSE
SGMD.V
Salona Global Medical Device Corporation.
0.22 CAD
TSX
HTL.V
Hamilton Thorne Ltd..
1.45 CAD
TSX

Frequently Asked Question

What is Abiomed, Inc. (ABMD) total assets?

Abiomed, Inc. (ABMD) total assets is 1673393000.000.

What is enterprise annual revenue?

The annual revenue is 543070000.000.

What is firm profit margin?

Firm profit margin is 0.818.

What is company free cash flow?

The free cash flow is 5.493.

What is enterprise net profit margin?

The net profit margin is 0.132.

What is firm total revenue?

The total revenue is 0.361.

What is Abiomed, Inc. (ABMD) net profit (net income)?

The net profit (net income) is 136505000.000.

What is firm total debt?

The total debt is 0.000.

What is operating expences number?

The operating expences are 586889000.000.

What is company cash figure?

Enretprise cash is 182335000.000.